$ Value
—
Shares
136,286
Price
—
Filed
Aug 11
Insider
Name
WELDON WILLIAM C
Title
—
CIK
0001189019
Roles
Transaction Details
Transaction Date
2025-08-11
Code
C
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
192,562
Footnotes
Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis. | Each share of Series F preferred stock and Series F-1 preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis. | The option will vest in full on the earlier of Heartflow's annual meeting of shareholders in 2026 and the first anniversary of the grant date, subject to continued service through such date.
Filing Info
WELDON WILLIAM C's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-08-11 | HTFL | C | — |
| 2025-08-11 | HTFL | C | — |
| 2025-08-11 | HTFL | C | — |
| 2025-08-11 | HTFL | C | — |
| 2025-08-07 | HTFL | A | $0 |
Other Insiders at HTFL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| BARABE TIMOTHY C | — | — | 2026-03-11 |
| HealthCor Partners Management LP | — | — | 2026-03-24 |
| Lightcap Jeffrey C | — | — | 2026-03-24 |
|
Rogers Campbell
Chief Medical Officer
|
— | $4.8M | 2026-04-01 |
| Bain Capital Life Sciences Investors, LLC | — | $56.1M | 2026-02-04 |
| Cullivan Julie A | — | $447K | 2026-03-05 |
|
Farquhar John C.M.
Chief Executive Officer
|
— | $1.8M | 2026-04-10 |
|
Jones Marie L.
Chief Accounting Officer, VP
|
— | — | 2026-02-06 |
|
Verghese Vikram
Chief Financial Officer
|
— | — | 2026-02-06 |